Incyte

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Incyte and other ETFs, options, and stocks.

About INCY

Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of proprietary therapeutics. Its portfolio includes compounds in various stages, ranging from preclinical to late stage development, and commercialized products such as JAKAFI (ruxolitinib), and ICLUSIG (ponatinib).

CEO

Herve Hoppenot

CEOHerve Hoppenot

Employees

2,094

Employees2,094

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

1991

Founded1991

Employees

2,094

Employees2,094

INCY Key Statistics

Market cap

14.82B

Market cap14.82B

Price-Earnings ratio

15.67

Price-Earnings ratio15.67

Dividend yield

—

Dividend yield—

Average volume

1.36M

Average volume1.36M

High today

$67.91

High today$67.91

Low today

$66.56

Low today$66.56

Open price

$66.84

Open price$66.84

Volume

1.61M

Volume1.61M

52 Week high

$84.86

52 Week high$84.86

52 Week low

$61.91

52 Week low$61.91

INCY News

Simply Wall St 4d

Incyte Corporation's Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Incyte (NASDAQ:INCY) has had a rough three months with its share price down 12%. However, stock prices are usually driven by a company’s financial performance o...

Analyst ratings

52%

of 21 ratings

Buy

52.4%

Hold

42.9%

Sell

4.8%

INCY Earnings

$0.00

$0.39

$0.79

$1.18

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 1, Pre-Market

ActualExpected Nov 1, Pre-Market